ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978

NHGRI’s ENCODE project to identify all genome parts.

October 10, 2003

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011